[A novel gene delivery system targeting to epidermal growth factor receptor overexpressing cancer cells].
A polypeptide with 33 amino acid residues was designed and synthesized. Its C terminal was composed of multiple lysine residues, which played as a DNA condensing agent, whereas the N terminal was the receptor binding domain of Epidermal Growth Factor(N32-K48). Through a spontaneous self-assembly process with electrostatic interaction, the synthetic peptide combined with a luciferase expression vector, pEBluc, to form an EGF receptor targeting nucleic acid complex. Significant luciferase activity was detected 48 hours after adding this complex directly to the culture medium of the A431 cells. This synthetic peptide could be used to construct a gene transfer system mediated by the endocytosis via EGF receptor. It promoted a very possibility of the gene therapy for the cancers such as glioma, melanoma and squamous carcinoma which are known of epidermal growth factor receptor overexpression.
Gong
H
H
National Laboratory of Molecular Virology and Genetic Engineering, Beijing 100052.
Wu
X
X
Shu
Y
Y
D002277:Carcinoma / Q000473:pathology; D004247:DNA / Q000378:metabolism; D066246:ErbB Receptors / Q000378:metabolism*; D018014:Gene Transfer Techniques; D015316:Genetic Therapy; D006801:Humans; D008156:Luciferases / Q000378:metabolism; D008175:Lung Neoplasms / Q000473:pathology; D014162:Transfection; D014407:Tumor Cells, Cultured
D004247:DNA; D008156:Luciferases; D066246:ErbB Receptors